| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,990 | $30 | $129.7K |
| J3262 | Injection, tocilizumab, 1 mg | 17,760 | $10 | $88.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 8,250 | $10 | $82.5K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1,900 | $30 | $64.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 480 | $90 | $42.3K |
| J0897 | Injection, denosumab, 1 mg | 2,100 | $20 | $37.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 210 | $100 | $20.2K |
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 630 | $20 | $11.3K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 100 | $110 | $11.3K |
| 20610 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 50 | $50 | $2.6K |